De‐Zhen Guo

449 total citations
25 papers, 137 citations indexed

About

De‐Zhen Guo is a scholar working on Cancer Research, Hepatology and Molecular Biology. According to data from OpenAlex, De‐Zhen Guo has authored 25 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 10 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in De‐Zhen Guo's work include Cancer Genomics and Diagnostics (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). De‐Zhen Guo is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). De‐Zhen Guo collaborates with scholars based in China, Ethiopia and India. De‐Zhen Guo's co-authors include Ao Huang, Xin‐Rong Yang, Yupeng Wang, Jia Fan, Jiayan Yan, Shiyu Zhang, Jianwen Cheng, Jian Zhou, Yabing Cao and Jia Fan and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

De‐Zhen Guo

25 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
De‐Zhen Guo China	7	67	47	40	40	34	25	137
Carmen Andreu-Oller Spain	2	73 1.1×	34 0.7×	44 1.1×	43 1.1×	34 1.0×	2	125
Tobias Meischl Austria	7	57 0.9×	57 1.2×	44 1.1×	34 0.8×	14 0.4×	18	125
Hiroaki Kanzaki Japan	7	66 1.0×	27 0.6×	37 0.9×	44 1.1×	76 2.2×	19	164
Jasmine J. Wang United States	6	87 1.3×	51 1.1×	80 2.0×	61 1.5×	63 1.9×	9	209
Joseph Hreiki United States	5	66 1.0×	74 1.6×	39 1.0×	19 0.5×	55 1.6×	6	159
Kengo Kanayama Japan	7	47 0.7×	45 1.0×	25 0.6×	33 0.8×	61 1.8×	10	160
Wen‐Bin Ding China	6	67 1.0×	49 1.0×	77 1.9×	51 1.3×	75 2.2×	11	199
Undarmaa Tudev Mongolia	4	37 0.6×	29 0.6×	46 1.1×	27 0.7×	29 0.9×	5	111
Katsumi Terashita Japan	7	77 1.1×	55 1.2×	39 1.0×	33 0.8×	67 2.0×	8	189

Countries citing papers authored by De‐Zhen Guo

Since Specialization

Citations

This map shows the geographic impact of De‐Zhen Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De‐Zhen Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De‐Zhen Guo more than expected).

Fields of papers citing papers by De‐Zhen Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De‐Zhen Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De‐Zhen Guo. The network helps show where De‐Zhen Guo may publish in the future.

Co-authorship network of co-authors of De‐Zhen Guo

This figure shows the co-authorship network connecting the top 25 collaborators of De‐Zhen Guo. A scholar is included among the top collaborators of De‐Zhen Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De‐Zhen Guo. De‐Zhen Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, De‐Zhen, Xin Zhang, Shiyu Zhang, et al.. (2024). Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Molecular Cancer. 23(1). 157–157. 22 indexed citations

Zhang, Xin, Peixin Huang, Bin Ma, et al.. (2024). Detection of urine circulating tumor DNA using droplet digital PCR for predicting hepatocellular carcinoma recurrence. Hepatoma Research. 1 indexed citations

Guo, De‐Zhen, Ao Huang, Ying‐Chao Wang, et al.. (2024). Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study. Clinical and Translational Medicine. 14(5). e1652–e1652. 18 indexed citations

Liu, Zhiyong, Xiahui Lin, Danying Zhang, et al.. (2024). Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis. Advanced Science. 11(46). e2407517–e2407517. 5 indexed citations

Guo, De‐Zhen, et al.. (2024). Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.. Journal of Clinical Oncology. 42(16_suppl). 4125–4125. 2 indexed citations

Huang, Ao, De‐Zhen Guo, Ying Sun, et al.. (2023). Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer. Hepatology International. 18(1). 254–264. 7 indexed citations

Guo, De‐Zhen, Shiyu Zhang, Jiayan Yan, et al.. (2023). Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy. Frontiers in Oncology. 13. 1109742–1109742. 6 indexed citations

Wang, Yupeng, Ao Huang, De‐Zhen Guo, et al.. (2023). Evaluating prognostic value of biliary stone in intrahepatic cholangiocarcinoma by propensity score matching analysis. Journal of Cancer. 14(7). 1257–1271. 5 indexed citations

Guo, De‐Zhen, Shiyu Zhang, Jiayan Yan, et al.. (2023). Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy. Frontiers in Immunology. 14. 1141199–1141199. 5 indexed citations

10.

Zhang, Shiyu, De‐Zhen Guo, Xin Zhang, et al.. (2023). Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study. Journal of Cancer Research and Clinical Oncology. 149(11). 8889–8896. 5 indexed citations

11.

Liu, Rui, De‐Zhen Guo, Ao Huang, et al.. (2023). Development and validation of a non-invasive cfDNA targeted sequencing assay for early-stage hepatocellular carcinoma detection using cfDNA methylation and fragmentomics.. Journal of Clinical Oncology. 41(16_suppl). 4128–4128. 2 indexed citations

12.

Xu, Xin, Ao Huang, De‐Zhen Guo, et al.. (2022). Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma. Frontiers in Oncology. 12. 893268–893268. 1 indexed citations

13.

Yang, Xin‐Rong, Rui Liu, Jian Zhou, et al.. (2022). Discovery and clinical validation of cost-effective noninvasive early detection of hepatocellular carcinoma (HCC) through circulating tumor DNA (ctDNA) methylation signature.. Journal of Clinical Oncology. 40(16_suppl). 4103–4103. 1 indexed citations

14.

Huang, Junfeng, Qing Miao, Jian‐Wen Cheng, et al.. (2022). Metagenomic Next-Generation Sequencing Versus Traditional Laboratory Methods for the Diagnosis and Treatment of Infection in Liver Transplantation. Frontiers in Cellular and Infection Microbiology. 12. 886359–886359. 5 indexed citations

15.

Guo, De‐Zhen, Jianwen Cheng, Jiayan Yan, et al.. (2022). Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria. Annals of Translational Medicine. 10(20). 1091–1091. 5 indexed citations

16.

Huang, Ao, De‐Zhen Guo, Yupeng Wang, et al.. (2022). The treatment strategy and outcome for spontaneously ruptured hepatocellular carcinoma: a single-center experience in 239 patients. Journal of Cancer Research and Clinical Oncology. 148(11). 3203–3214. 9 indexed citations

17.

Song, Guohe, De‐Zhen Guo, Zhijie Zhou, et al.. (2022). Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma. Journal of Cancer. 13(2). 610–622. 7 indexed citations

18.

Guo, De‐Zhen, et al.. (2021). 956P A multi-analyte liquid biopsy assay integrating cfDNA methylation and protein biomarkers for liver cancer diagnosis. Annals of Oncology. 32. S828–S828. 2 indexed citations

19.

Yin, Yue, Jianwen Cheng, Feiyu Chen, et al.. (2021). A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma. Annals of Translational Medicine. 9(9). 774–774. 6 indexed citations

20.

Guo, De‐Zhen, Yupeng Wang, Guo‐Huan Yang, et al.. (2021). Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation. Journal of Cancer. 12(23). 7190–7200. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact